Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00920569 · ClinicalTrials.gov registry record
Recirculation, Oxygenator Blood Volume and Cardiac Output Measurements During Extracorporeal Membrane Oxygenation
A clinical trial, sponsored by Transonic Systems.
- Terminated
- Registry status
- 8
- Enrollment target
NCT00920569 is a clinical trial that was terminated before completion, run by Transonic Systems. The registered enrollment target is 8 participants.
The verdict
NCT00920569 was terminated before completion, sponsored by Transonic Systems.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
This study is to test the usefulness of ultrasound dilution measurements in patients on extracorporeal membrane oxygenation. Measurements may include; efficiency of support (recirculation), amount of clotting in the oxygenator (oxygenator blood volume), and how well the heart is working (cardiac output). At the present time there are no devices available to perform these functions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2006-05 |
| Est. Completion | 2008-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00920569
The ClinicalTrials.gov registry entry for NCT00920569 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Transonic Systems, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00920569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00920569 about?
NCT00920569 is a clinical study titled "Recirculation, Oxygenator Blood Volume and Cardiac Output Measurements During Extracorporeal Membrane Oxygenation". This study is to test the usefulness of ultrasound dilution measurements in patients on extracorporeal membrane oxygenation. Measurements may include; efficiency of support (recirculation), amount of clotting in the oxygenator (oxygenator blood volume), and how well the heart is working (cardiac out...
What is the current status of trial NCT00920569?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2006-05. Estimated completion is 2008-08.
Who is sponsoring clinical trial NCT00920569?
This trial is sponsored by Transonic Systems, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.